LMRI — Lumexa Imaging Holdings Inc · catalysts, narrative & risks

Lumexa Imaging Holdings Inc. (NASDAQ: LMRI) — Research Note as of 2026-10-27

Not investment advice. All figures are point-in-time from third-party sources and may contain inconsistencies (see critical reflection at the end).

Company Snapshot

As of Oct 27, 2026, LMRI trades on NASDAQ at ~$11.67, with a market cap of ~$1.12B and ~96.07M shares outstanding [17]. It is one of the largest U.S. outpatient imaging operators, described as having the second-largest diagnostic imaging footprint in the U.S., operating roughly 180–190 centers across 13 states, 85+ of which are joint ventures (JVs) with major health systems [8], [22], [24]. The stock has underperformed, down ~36.5% year-to-date, within a 52-week range of $6.45–$19.45 [14], [17].

Recent Catalysts (last ~1–3 months)